The aim of the Scottish Mesothelioma MDT is to discuss and plan the management of all patients with a confirmed new diagnosis of mesothelioma and all patients where a diagnostic or therapeutic decision needs multidisciplinary input i.e patients with progressive disease.
The MDT ensures:
- Decisions regarding diagnosis, treatment and care are based on national guidelines and protocols where these exist
- Prompt effective multidisciplinary decision making
- Patients and with their consent, carers, are involved as partners in timely decisions and receive information about their treatment
- Improves co-ordination, communication and information flows with all appropriate health care professionals
- All mechanisms are in place to support entry of eligible patients into clinical trials, subject to patients giving fully informed consent
- Assistance with clinical audit that informs the changes required to improve the quality of patient care through Quality Performance Indicators (QPIs)
- To act as a multi-professional education forum ensuring continuous professional development
Weekly Scotland Wide Mesothelioma MDT
The MDT meeting is held on a weekly basis and is attended by Respiratory Consultants and Clinical Nurse Specialists from multiple sites across Scotland as well as consultants from Radiology, Pathology, Oncology, Cardiothoracic surgery and Palliative Care.
MDT Referral Process
To refer a patient to the Scottish National MDT, please complete all non-shaded sections of the MDT referral form (Scottish Mesothelioma Referral Form V4) and email to scottish.mesotheliomamdt@nhs.scot The Mesothelioma MDT is held every Friday @ 1.30pm. The cut off date for referrals is 9 o’clock on the Thursday before MDT and all outcomes will be forwarded to the referring clinician Friday afternoon. Any referrals received after 9.00am on the Thursday will be discussed the following week. Due to COVID-19, the Scottish Mesothelioma MDT is currently held virtually via MS teams.